Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeru Shiroiwa

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Clinical Therapeutics|November 29, 2007
Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in JapanTakeru Shiroiwa, Takashi Fukuda, Kiichiro Tsutani
Neuromodulation : Journal of the International Neuromodulation Society|April 27, 2018
Cost-Minimization Analysis of Deep-Brain Stimulation Using National Database of Japanese Health Insurance ClaimsManabu Akazawa, Keiko Konomura, Takeru Shiroiwa
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 24, 2009
Health utility scores of colorectal cancer based on societal preference in JapanTakeru Shiroiwa, Takashi Fukuda, Kiichiro Tsutani
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
What Is a Valid Mapping Algorithm in Cost-Utility Analyses? A Response From a Missing Data PerspectiveYasuhiro Hagiwara, Takuya Kawahara, Takeru Shiroiwa
International Journal of Environmental Research and Public Health|October 13, 2021
Estimation of Lifetime QALYs Based on Lifestyle BehaviorsShinichi Noto, Shota Saito, Takeru Shiroiwa, et al.
Pharmacoeconomics|March 27, 2016
The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in JapanHaruhisa Fukuda, Shunya Ikeda, Takeru Shiroiwa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
QALY and productivity loss: empirical evidence for "double counting"Takeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
Health Policy (Amsterdam, Netherlands)|July 9, 2017
New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluationsTakeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
Cost Effectiveness and Resource Allocation : C/E|October 17, 2013
WTP for a QALY and health states: More money for severer health states?Takeru Shiroiwa, Ataru Igarashi, Takashi Fukuda, et al.
Journal of Patient Safety|October 19, 2022
Critical Incident Reports Related to Ventilator Use: Analysis of the Japan Quality Council National DatabaseNaomi Akiyama, Shihoko Kajiwara, Takahiro Tamaki, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical Therapeutics|November 29, 2007
Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in JapanTakeru Shiroiwa, Takashi Fukuda, Kiichiro Tsutani
Neuromodulation : Journal of the International Neuromodulation Society|April 27, 2018
Cost-Minimization Analysis of Deep-Brain Stimulation Using National Database of Japanese Health Insurance ClaimsManabu Akazawa, Keiko Konomura, Takeru Shiroiwa
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 24, 2009
Health utility scores of colorectal cancer based on societal preference in JapanTakeru Shiroiwa, Takashi Fukuda, Kiichiro Tsutani
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
What Is a Valid Mapping Algorithm in Cost-Utility Analyses? A Response From a Missing Data PerspectiveYasuhiro Hagiwara, Takuya Kawahara, Takeru Shiroiwa
International Journal of Environmental Research and Public Health|October 13, 2021
Estimation of Lifetime QALYs Based on Lifestyle BehaviorsShinichi Noto, Shota Saito, Takeru Shiroiwa, et al.
Pharmacoeconomics|March 27, 2016
The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in JapanHaruhisa Fukuda, Shunya Ikeda, Takeru Shiroiwa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
QALY and productivity loss: empirical evidence for "double counting"Takeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
Health Policy (Amsterdam, Netherlands)|July 9, 2017
New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluationsTakeru Shiroiwa, Takashi Fukuda, Shunya Ikeda, et al.
Cost Effectiveness and Resource Allocation : C/E|October 17, 2013
WTP for a QALY and health states: More money for severer health states?Takeru Shiroiwa, Ataru Igarashi, Takashi Fukuda, et al.
Journal of Patient Safety|October 19, 2022
Critical Incident Reports Related to Ventilator Use: Analysis of the Japan Quality Council National DatabaseNaomi Akiyama, Shihoko Kajiwara, Takahiro Tamaki, et al.
Pageof 7